Provocation of schizophrenic symptoms by intravenous administration of methylphenidate

Arch Gen Psychiatry. 1973 Feb;28(2):185-91. doi: 10.1001/archpsyc.1973.01750320023004.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Bipolar Disorder / diagnosis
  • Brain Chemistry / drug effects
  • Chlorpromazine / therapeutic use
  • Clinical Trials as Topic
  • Dopamine / metabolism
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Male
  • Methylphenidate* / administration & dosage
  • Methylphenidate* / pharmacology
  • Norepinephrine / metabolism
  • Parenteral Nutrition
  • Placebos
  • Psychiatric Status Rating Scales
  • Remission, Spontaneous
  • Schizophrenia / chemically induced
  • Schizophrenia / diagnosis*
  • Schizophrenia / drug therapy
  • Schizophrenic Psychology

Substances

  • Placebos
  • Methylphenidate
  • Chlorpromazine
  • Dopamine
  • Norepinephrine